Advertisement

Topics

. @Agilent aims for growth in live cell analysis for immuno-oncology and #immunotherapy markets through its planned $1.165B acquisition of @BioTekTalk: http://ow.ly/JM3M50uZrE7 

17:55 EDT 12 Jul 2019 | Genetic Engineering News

. aims for growth in live cell analysis for immuno-oncology and markets through its planned $1.165B acquisition of : http://ow.ly/JM3M50uZrE7 

Original Article: . @Agilent aims for growth in live cell analysis for immuno-oncology and #immunotherapy markets through its planned $1.165B acquisition of @BioTekTalk: http://ow.ly/JM3M50uZrE7 

NEXT ARTICLE

More From BioPortfolio on ". @Agilent aims for growth in live cell analysis for immuno-oncology and #immunotherapy markets through its planned $1.165B acquisition of @BioTekTalk: http://ow.ly/JM3M50uZrE7 "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...